Continuous Glucose Monitoring in Polycystic Ovarian Syndrome

Conditions

• Polycystic Ovarian Syndrome (PCOS)

Eligibility Criteria

Sex

ALL

Age

18 Years - 45 Years

Healthy Volunteers

Not accepted

Interventions

• Stelo glucose biosensor by Dexcom — DEVICE
  Unblinded continuous glucose monitoring (CGM) system

Study Details

The purpose of this study is to learn more about blood sugar control in polycystic ovarian syndrome. The patient will be asked to wear a continuous glucose monitor (CGM) device that is applied to the arm with a sensor or filament that goes under the skin to measure your sugar levels. The patient will wear this at certain time points throughout the study. There will have a total of 2 blood draws (about 1 tsp. of blood) at screening and the 6-month visit, a measure of the patients body muscle and fat (body composition), and fill out a questionnaire at the end of the first 3 months and 6 months. Study participation in the research will last about 6 months.

Key Dates

Start date

Dec 24, 2025

Status verified

Jan 2026

Primary completion

Dec 31, 2026

Completion

Aug 15, 2027

Study Design

Enrollment

40 participants (estimated)

Arms

• Arm: Patients with Polycystic Ovarian Syndrome
  Patients with Polycystic Ovarian Syndrome

Primary Outcome Measure

Continuous Glucose measure derived glucometrics [ Time Frame: 6 months ]

Locations (1)

Find similar trials in Cleveland, OH